Get the Stockscreener App
0.2314
4.23%
0.0094
After Hours:
.22
-0.0114
-4.93%
Viracta Therapeutics Inc Stock (VIRX) Forecast
The Viracta Therapeutics Inc (VIRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.8542, representing a +701.30% increase from the current price of $0.2314. The highest analyst price target is $2.8503, and the lowest is $0.8581.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VIRX Price Target
Average 1.846
(+697.77% Upside)
Is Viracta Therapeutics Inc (VIRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 38.60 | Neutral |
| STOCH(9,6) | 35.04 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.0261 | Buy |
| ADX(14) | 27.26 | Sell |
| William %R | -60.41 | Neutral |
| CCI(14) | -19.50 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.2233
Buy
|
0.2269
Buy
|
| MA20 |
0.2311
Buy
|
0.2407
Sell
|
| MA50 |
0.3258
Sell
|
0.3223
Sell
|
| MA100 |
0.4806
Sell
|
0.4447
Sell
|
| MA200 |
0.6187
Sell
|
0.6279
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, VIRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 9 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on VIRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 38.6 indicates that VIRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 35.04 indicates that VIRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that VIRX is oversold. This suggests that VIRX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 27.26 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -19.5 indicates that VIRX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term VIRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Viracta Therapeutics Inc financial reports and earnings history, Viracta Therapeutics Inc (VIRX) stock could reach $5.2417 by 2030, $24.36 by 2040 and $46.09 by 2050. See the projected annual prices until 2050 of the Viracta Therapeutics Inc stock below:
- Viracta Therapeutics Inc (VIRX) is expected to reach an average price of $1.6099 in 2035, with a high prediction of $1.6715 and a low estimate of $1.5484. This indicates an $595.73% rise from the last recorded price of $0.2314.
- Viracta Therapeutics Inc (VIRX) stock is projected to chart a bullish course in 2040, with an average price target of $23.66, representing an $10,125% surge from its current level. The forecast ranges from a conservative $24.04 to a sky-high $24.36.
- Our analysts predict Viracta Therapeutics Inc (VIRX) to jump 5,329% by 2045, soaring from $12.60 to an average price of $12.56, potentially reaching $13.26. While $12.60 is the low estimate, the potential upside is significant.
- Viracta Therapeutics Inc (VIRX) stock is expected to climb by 2050, reaching an average of $46.40, a $19,952% jump from its current level. However, a wide range of estimates exists, with high and low targets of $46.09 and $46.43, respectively, highlighting the market's uncertainty.
Viracta Therapeutics Inc Stock (VIRX) Year by Year Forecast
Viracta Therapeutics Inc Stock (VIRX) Price Forecast for 2024
Our forecast for VIRX stock price in 2024 now indicates an average price target of $2.8298 with a high forecast of $5.6141 and a low forecast of $0.0455. The average prediction reflects an increase of +1,123% from the last recorded price of $0.2314.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2024 | $1.8269 | $0.8581 | $2.8503 | +689.50% |
| December, 2024 | $0.6923 | $0.5123 | $2.0746 | +199.19% |
Viracta Therapeutics Inc Stock (VIRX) Price Forecast for 2025
Viracta Therapeutics Inc Stock (VIRX) is expected to reach an average price of $1.846 in 2025, with a high prediction of $3.2883 and a low estimate of $0.4038. This indicates an +697.77% rise from the last recorded price of $0.2314.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.0734 | $0.4038 | $0.7012 | +363.87% |
| February, 2025 | $2.278 | $1.2945 | $1.488 | +884.43% |
| March, 2025 | $2.5725 | $2.3591 | $2.3514 | +1,012% |
| April, 2025 | $3.3483 | $2.9637 | $3.2883 | +1,347% |
| May, 2025 | $3.0229 | $3.1617 | $3.1294 | +1,206% |
| June, 2025 | $2.6074 | $3.124 | $3.0163 | +1,027% |
| July, 2025 | $1.4632 | $0.872 | $1.6286 | +532.30% |
| August, 2025 | $3.4977 | $2.9243 | $2.7877 | +1,412% |
| September, 2025 | $2.8123 | $3.1923 | $3.0762 | +1,115% |
| October, 2025 | $1.348 | $1.418 | $2.4646 | +482.55% |
| November, 2025 | $1.5426 | $1.0003 | $0.8926 | +566.64% |
| December, 2025 | $0.6183 | $0.796 | $0.8503 | +167.21% |
Viracta Therapeutics Inc Stock (VIRX) Price Forecast for 2026
The predicted value for Viracta Therapeutics Inc (VIRX) in 2026 is set at an average of $1.3811. Estimates vary from a peak of $2.4312 to a trough of $0.3309, indicating an +496.83% surge from the present price of $0.2314.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.4629 | $0.5406 | $1.1982 | +100.05% |
| February, 2026 | $0.4875 | $0.5552 | $0.2775 | +110.67% |
| March, 2026 | $1.1921 | $0.3309 | $0.2891 | +415.15% |
| April, 2026 | $2.2978 | $1.6632 | $1.7878 | +892.99% |
| May, 2026 | $2.2124 | $2.3189 | $2.4312 | +856.08% |
| June, 2026 | $1.6169 | $1.7122 | $1.5169 | +598.77% |
| July, 2026 | $1.8027 | $1.6804 | $1.6052 | +679.03% |
| August, 2026 | $1.9472 | $1.755 | $1.6938 | +741.51% |
| September, 2026 | $1.863 | $1.8507 | $1.803 | +705.09% |
| October, 2026 | $1.5375 | $1.6475 | $1.8753 | +564.45% |
| November, 2026 | $1.2621 | $1.3521 | $1.4498 | +445.43% |
| December, 2026 | $1.1078 | $1.2477 | $1.2456 | +378.76% |
Viracta Therapeutics Inc Stock (VIRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Viracta Therapeutics Inc (VIRX) is $3.3173, with a high forecast of $6.6222 and a low forecast of $0.0123. This indicates an +1,334% increase from the last price of $0.2314.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.0524 | $1.0413 | $1.059 | +354.81% |
| February, 2027 | $0.877 | $0.917 | $0.9936 | +279.00% |
| March, 2027 | $1.3517 | $1.0893 | $1.0512 | +484.15% |
| April, 2027 | $1.3708 | $1.3821 | $1.305 | +492.40% |
| May, 2027 | $1.3019 | $1.3296 | $1.251 | +462.61% |
| June, 2027 | $1.1366 | $1.2076 | $1.2471 | +391.19% |
| July, 2027 | $0.9712 | $0.9455 | $0.9588 | +319.70% |
| August, 2027 | $0.7068 | $0.7868 | $0.8983 | +205.43% |
| September, 2027 | $0.2822 | $0.3325 | $0.5386 | +21.95% |
| October, 2027 | $0.0429 | $0.0129 | $0.1729 | -81.45% |
| November, 2027 | $0.00204 | $0.0123 | $0.3718 | -99.12% |
| December, 2027 | $6.2467 | $0.0172 | $6.6222 | +2,600% |
Viracta Therapeutics Inc Stock (VIRX) Price Forecast for 2028
In 2028, Viracta Therapeutics Inc (VIRX) is projected to reach an average price of $6.2842, with a high projection of $9.3165 and a low estimate of $3.2518. This indicates an +2,616% rise from the last price of $0.2314.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.6758 | $6.5258 | $6.7812 | +1,921% |
| February, 2028 | $4.785 | $5.625 | $5.2527 | +1,968% |
| March, 2028 | $3.4364 | $3.2518 | $4.457 | +1,385% |
| April, 2028 | $3.8556 | $3.4807 | $2.8433 | +1,566% |
| May, 2028 | $4.257 | $3.7952 | $3.957 | +1,740% |
| June, 2028 | $5.0562 | $4.9893 | $4.9362 | +2,085% |
| July, 2028 | $6.0353 | $5.5285 | $5.5753 | +2,508% |
| August, 2028 | $7.6068 | $7.0926 | $6.8868 | +3,187% |
| September, 2028 | $8.6559 | $7.7891 | $7.8659 | +3,641% |
| October, 2028 | $8.7951 | $8.6982 | $8.6128 | +3,701% |
| November, 2028 | $9.3765 | $9.1474 | $9.3165 | +3,952% |
| December, 2028 | $8.8957 | $9.0734 | $9.1188 | +3,744% |
Viracta Therapeutics Inc Stock (VIRX) Price Forecast for 2029
The 2029 price forecast for Viracta Therapeutics Inc Stock (VIRX) is $6.373 on average, with a high prediction of $8.7726 and a low estimate of $3.9734. This represents an +2,654% increase from the previous price of $0.2314.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $7.5171 | $8.4071 | $8.7726 | +3,149% |
| February, 2029 | $6.9863 | $6.434 | $6.3263 | +2,919% |
| March, 2029 | $8.8655 | $8.4086 | $8.1555 | +3,731% |
| April, 2029 | $8.0246 | $8.4046 | $8.3723 | +3,368% |
| May, 2029 | $6.3661 | $6.4361 | $7.5992 | +2,651% |
| June, 2029 | $6.4052 | $5.9129 | $5.7552 | +2,668% |
| July, 2029 | $5.2644 | $5.5421 | $5.674 | +2,175% |
| August, 2029 | $4.9758 | $3.9734 | $5.1267 | +2,050% |
| September, 2029 | $4.845 | $4.9904 | $4.6727 | +1,994% |
| October, 2029 | $5.7364 | $4.5718 | $5.1164 | +2,379% |
| November, 2029 | $6.3056 | $5.8787 | $5.7956 | +2,625% |
| December, 2029 | $6.0647 | $6.2879 | $6.3224 | +2,521% |
Viracta Therapeutics Inc Stock (VIRX) Price Forecast for 2030
Viracta Therapeutics Inc Stock (VIRX) is expected to reach an average price of $4.2021 in 2030, with a high forecast of $5.2417 and a low forecast of $3.1625. This signifies an +1,716% surge from the last price of $0.2314.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.4162 | $5.4339 | $5.2417 | +2,241% |
| February, 2030 | $5.3053 | $5.2608 | $5.1085 | +2,193% |
| March, 2030 | $5.2945 | $5.1799 | $5.1576 | +2,188% |
| April, 2030 | $5.0636 | $5.0814 | $4.9268 | +2,088% |
| May, 2030 | $4.5351 | $4.6451 | $4.9559 | +1,860% |
| June, 2030 | $4.1043 | $4.1943 | $4.3697 | +1,674% |
| July, 2030 | $3.7557 | $3.8956 | $4.0265 | +1,523% |
| August, 2030 | $3.5449 | $3.5726 | $3.668 | +1,432% |
| September, 2030 | $3.214 | $3.254 | $3.4471 | +1,289% |
| October, 2030 | $3.4945 | $3.3486 | $3.2032 | +1,410% |
| November, 2030 | $3.3581 | $3.3694 | $3.37 | +1,351% |
| December, 2030 | $3.1338 | $3.1625 | $3.197 | +1,254% |
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):